Total medical devices industry M&A deals in Q2 2019 worth $13.43bn were announced in the US, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked an increase of 72.8% over the previous quarter and a rise of 133.9% when compared with the last four-quarter average of $5.74bn.
The US held a 91.3% share of the global medical devices industry M&A deal value that totalled $14.71bn in Q2 2019.
In terms of deal activity, the US recorded 47 deals during Q2 2019, marking a drop of 9.6% over the previous quarter and a drop of 4.1% over the last four-quarter average.
The US medical devices industry M&A deals in Q2 2019: Top deals
The top five medical devices industry M&A deals accounted for 98.7% of the overall value during Q2 2019.
The combined value of the top five medical devices industry M&A deals stood at $13.25bn, against the overall value of $13.43bn recorded for the quarter. The top announced medical devices industry M&A deal tracked by GlobalData in Q2 2019 was 3M’s $6.73bn acquisition of Acelity.
In second place was the $5.8bn acquisition of Medidata Solutions by Dassault Systemes and in third place was Boston Scientific’s $465m acquisition of VertiFlex.
The $167.5m asset transaction with AngioDynamics by Medline Industries and Misonix’s acquisition of Soluble Systems for $97m held fourth and fifth positions, respectively.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.